Clinical Trials Browser

Phase 1/2 × adagrasib × Tumor-Agnostic × Clear all

NCT04418661 2025-05-29

Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies

Phase 1/2 Terminated

65 enrolled 32 charts

Neoplasm Metastasis